Follow
Anthony Rizzardi
Anthony Rizzardi
Research Scientist
Verified email at uw.edu
Title
Cited by
Cited by
Year
Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
AE Rizzardi, AT Johnson, RI Vogel, SE Pambuccian, J Henriksen, ...
Diagnostic pathology 7, 1-10, 2012
4952012
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance
AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ...
Cancer discovery 3 (6), 674-689, 2013
1142013
Evaluation of protein biomarkers of prostate cancer aggressiveness
AE Rizzardi, NK Rosener, JS Koopmeiners, R Isaksson Vogel, ...
BMC cancer 14, 1-14, 2014
812014
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
SH Isakson, AE Rizzardi, AW Coutts, DF Carlson, MN Kirstein, J Fisher, ...
Communications biology 1 (1), 158, 2018
652018
Elevated hyaluronan and hyaluronan‐mediated motility receptor are associated with biochemical failure in patients with intermediate‐grade prostate tumors
AE Rizzardi, RI Vogel, JS Koopmeiners, CL Forster, LO Marston, ...
Cancer 120 (12), 1800-1809, 2014
552014
CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy
L Ding, S Chen, P Liu, Y Pan, J Zhong, KM Regan, L Wang, C Yu, ...
Cancer research 74 (7), 2050-2061, 2014
552014
The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin
A Srirangam, M Milani, R Mitra, Z Guo, M Rodriguez, H Kathuria, ...
Journal of Thoracic Oncology 6 (4), 661-670, 2011
502011
Safe and effective sarcoma therapy through bispecific targeting of EGFR and uPAR
A Borgatti, JS Koopmeiners, AL Sarver, AL Winter, K Stuebner, ...
Molecular cancer therapeutics 16 (5), 956-965, 2017
472017
Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer
AE Rizzardi, X Zhang, RI Vogel, S Kolb, MS Geybels, YK Leung, ...
Diagnostic pathology 11, 1-11, 2016
422016
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
PJ Beckmann, JD Larson, AT Larsson, JP Ostergaard, S Wagner, ...
Cancer research 79 (5), 905-917, 2019
412019
Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides
GJ Metzger, SC Dankbar, J Henriksen, AE Rizzardi, NK Rosener, ...
PloS one 7 (3), e33520, 2012
322012
Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis
EP Rahrmann, BS Moriarity, GM Otto, AL Watson, K Choi, MH Collins, ...
The American journal of pathology 184 (7), 2082-2098, 2014
292014
Canonical Wnt/β-catenin signaling drives human Schwann cell transformation, progression, and tumor maintenance. Cancer Discov. 2013; 3: 674–689. doi: 10.1158/2159-8290
AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ...
Cell 152 (5), 1077-90, 2013
232013
Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant …
DM Seelig, D Ito, CL Forster, UA Yoon, M Breen, LJ Burns, V Bachanova, ...
Leukemia & lymphoma 58 (7), 1702-1710, 2017
152017
Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E-and IHC-stained histopathological specimens
E Leng, JC Henriksen, AE Rizzardi, J Jin, JW Nam, BM Brassuer, ...
Scientific reports 9 (1), 6992, 2019
102019
Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma
B Charbonneau, RI Vogel, JC Manivel, A Rizzardi, SC Schmechel, ...
Human pathology 44 (9), 1918-1926, 2013
72013
Elevated HA and HMMR are associated with biochemical failure in patients with intermediate grade prostate tumors
AE Rizzardi, RI Vogel, JS Koopmeiners, CL Forster, LO Marston, ...
Cancer 120 (12), 1800, 2014
52014
Genetically engineered minipigs model the major clinical features of human
SH Isakson, AE Rizzardi, AW Coutts
Communications, 2018
2018
Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4
N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ...
LABORATORY INVESTIGATION 95, 254A-254A, 2015
2015
Quantification of Tumor Heterogeneity in Whole Slide Images of Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4
N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ...
MODERN PATHOLOGY 28, 254A-254A, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20